Diagnostic Products Corp president andchief executive officer Sigi Ziering said he expects tomaintain the same compound average annal net income growth in1987 as the company has for the past five years.    "We expect the same performance in net income over the nextfive years as we have had in the past," Ziering said.    Over the past five years Ziering said the company has hadaverage compound net income growth of 32 pct annually with a 27pct per year growth in earnings per share. For 1986 the companyhad net income of 6.3 mln dlrs, or 1.07 dlrs per share, vs 3.9mln dlrs, or 73 cts per share in 1985.    Diagnostic manufactures medical immunological diagnostictest kits.    Ziering said he expects the earnings growth to result frompositive effect of the weaker dollar on the company's exportssales as well as accelerated market penetration. Ziering saidhe expected the Food and Drug Administration to approve threemore of its drug abuse test kits by the end of the year, which,depending on approval, should also help earnings growth.    Ziering said as a result of the new tax laws he expectedthe company's taxes to decrease by five pct to 31 pct of netincome in 1987.    Reuter&#3;